Yanelys Gil
Nurse Practitioner · Miami, FLNPI 1164910444
Payments from drug & device makers
Across 212 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$697
- Scilex Pharmaceuticals Inc.$468
- Lilly USA, LLC$279
- Pfizer$257
- Amgen$196
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,277100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 85 | $1,243 |
| Biohaven Pharmaceuticals, Inc. | 34 | $697 |
| Scilex Pharmaceuticals Inc. | 14 | $468 |
| Lilly USA, LLC | 13 | $279 |
| Pfizer | 13 | $257 |
| Amgen | 8 | $196 |
| Fisher & Paykel Healthcare Inc | 1 | $151 |
| Neurelis, Inc. | 7 | $138 |
| Upsher-smith Laboratories LLC | 8 | $133 |
| Teva Pharmaceuticals USA, Inc. | 5 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Neurocrine Biosciences, Inc. | 4 | $85 |
| AstraZeneca | 3 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $69 |
| Merz Pharmaceuticals, LLC | 3 | $64 |
| UCB, Inc. | 1 | $47 |
| Boston Scientific | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Johnson & Johnson | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Octapharma USA, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FISHER & PAYKEL HEALTHCARE$754
- ZTLido$151
- NURTEC ODT$125
How this compares
$4,277 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 51 | $78,059 |
| RizatriptanRizatriptan Benzoate | 20 | $682 |
| Sumatriptan Succinate | 11 | $315 |
| Cyclobenzaprine Hcl | 11 | $92 |
| Trazodone Hcl | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $257 | $78,05951 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Miami
- Margarita FernandezMiami$311K
- Maya BloombergMiami$202K
- Haydee KapinMiami$97K
- Terri PollackMiami$59K
- Amber FederizoMiami$39K
- Patricia Novoa-VogtMiami$35K
- Moriane JosephMiami$23K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.